Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. University Hospital Leuven, Leuven, Belgium



Survival: 11.1 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: Belgium
   
City/State/Province: Leuven
   
Hospital: University Hospital Leuven
   
Journal: Link
   
Date: 11/2013

Description:
Patients:
This phase 2 study involved 69 recurrent epithelial ovarian cancer patients with a median age of 61 years.

Treatment:
Patients received chemotherapy with etirinotecan pegol.

Toxicities:
There were two treatment-related deaths due to kidney failure and sepsis. Grade 3-4 dehydration, diarrhea, fatigue, and nausea were also reported.

Results:
The median overall survival was 11.1 months.

Support:
This study was supported by Nektar Therapeutics (makers of etirinotecan pegol).

Correspondence: Dr. Ignace Vergote; email: ignace.vergote@uzleuven.be

E-mail to a Friend Email Physician More Information